The flea and tick medicine involved in the warning are in the isoxazoline class, including Bravecto, Credelio, Nexgard, and Simparica. For more information from the FDA, click here.

According to the FDA, some animals receiving drugs in the isoxazoline class, including Bravecto, Nexgard and Simparica have experienced adverse events such as muscle tremors, ataxia, and seizures.

These include Bravecto, Credelio, Nexgard and Simparica. The U.S. Food and Drug Administration (FDA) issued a new warning this past week alerting pet owners and veterinarians of the potential for ...

Drugs in this class include Bravecto, Credelio, Nexgard and Simparica. The FDA said that these products can and have been safely used in the majority of dogs and cats, ...

The flavored tablet bested Merial's NexGard, a chewable approved by the FDA last year to prevent and kill fleas and ticks for up to a month. Both Quellin and Bravecto require veterinary prescriptions.

Only Bravecto and Nexgard are available in South Africa‚ the former since 2014. Many South African pet owners have reported their pets getting ill after using the products.